Quick Answer
PULSE BIOSCIENCES, INC. reported Cash and Equivalents of $80.73 million for fiscal year 2025.
PULSE BIOSCIENCES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $80.73M | -31.6% |
| 2024 | $118.04M | +166.1% |
| 2023 | $44.37M | -27.4% |
| 2022 | $61.14M | +113.7% |
| 2021 | $28.61M | +129.6% |
| 2020 | $12.46M | +80.6% |
| 2019 | $6.90M | -86.5% |
| 2018 | $51.10M | +1409.2% |
| 2017 | $3.39M | +62.1% |
| 2016 | $2.09M | -42.1% |
| 2015 | $3.61M | -48.6% |
| 2014 | $7.01M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $95.21M | +20.5% | -10.5% |
| June 30, 2025 | $106.35M | +306.0% | -10.8% |
| March 31, 2025 | $119.28M | +241.9% | +1.1% |
| December 31, 2024 | $118.04M | +166.1% | +49.4% |
| September 30, 2024 | $79.03M | +56.9% | +201.7% |
| June 30, 2024 | $26.20M | -55.4% | -24.9% |
| March 31, 2024 | $34.88M | -35.5% | -21.4% |
| December 31, 2023 | $44.37M | -27.4% | -11.9% |
- PULSE BIOSCIENCES, INC. showed a decrease of -31.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2014–2025 period, PULSE BIOSCIENCES, INC.’s cash and equivalents has grown by 1051.9% (from $7.01 million to $80.73 million).
- The most recent figure is from PULSE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: